QA: Nuvation Bio Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001811063_2023_Nuvation_Bio_Inc.pdf

Logs

Graph

Absolute values for 0001811063, Nuvation Bio Inc.

  xvar xval
0 AssetsCurrent 667,318,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 894,000
3 remainder_Assets 3,929,000
4 LiabilitiesCurrent 13,161,000
5 LiabilitiesNoncurrent 3,054,000
6 remainder_Liabilities 850,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,919,000
9 ResearchAndDevelopmentExpense 87,815,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 15,535,000
13 remainder_ComprehensiveNetIncome -4,341,000
  yvar yval
0 Assets 672,141,000
1 Liabilities 17,065,000
2 Expenses 119,734,000
3 Revenues 0
4 StockholdersEquity 655,076,000
5 NetIncome -104,199,000
6 ComprehensiveNetIncome -106,369,500
7 BaseVar 414,408,000
8 EconomicCapitalRatio 2.96

Edgar->Model Mapping

Feature Distribution

Change over Time